Short- and long-term follow-up of thyroid dysfunction after allogeneic bone marrow transplantation without the use of preparative total body irradiation

被引:40
作者
Toubert, ME
Socie, G
Gluckman, E
Aractingi, S
Esperou, H
Devergie, A
Ribaud, P
Parquet, N
Schlageter, MH
Beressi, JP
Rain, JD
Vexiau, P
机构
[1] HOP ST LOUIS,SERV GREFFE MOELLE,BONE MARROW TRANSPLANT UNIT,F-75475 PARIS 10,FRANCE
[2] HOP ST LOUIS,DEPT NUCL MED,F-75475 PARIS 10,FRANCE
[3] HOP ST LOUIS,DEPT DERMATOL,F-75475 PARIS 10,FRANCE
[4] HOP ST LOUIS,DEPT ENDOCRINOL & DIABETOL,F-75475 PARIS 10,FRANCE
关键词
bone marrow transplantation; thyroid dysfunction; chemotherapy; total body irradiation;
D O I
10.1046/j.1365-2141.1997.2433060.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We studied the incidence and potential prognostic value of thyroid abnormalities after allogeneic bone marrow transplantation (BMT) without total body irradiation (TBI) conditioning, 77 consecutive patients who received a chemotherapy-alone-based conditioning regimen pretransplant were included. Free serum thyroxine (FT4), free serum triiodothyronine (FT3) and serum thyrotropin (TSH) levels were assayed before and 3 and 14 months after BMT. Patients were classified in three categories: normal thyroid profile if FT3 and FT4 were within the normal range and TSH was normal or low, peripheral thyroid insufficiency (PTI) if TSH was >4 mIU/I, or an 'euthyroid sick syndrome' (ETS) if FT3 and/or FT4 were low and TSH was normal or low, The incidence of thyroid dysfunction at 3 months was 57%, and 29% at 14 months. This was mostly due to the occurrence of ETS which was more frequent at 3 months (48%, 29/61)than at 14 months (19%, 9/48), Furthermore, at 3 months, survival was significantly lower in the ETS group (34.5%) than in the euthyroid group (96:2%), or in the PTI group (83.3%) (P < 0.0001). PTI was observed even in the absence of TBI in 11 patients (14%) and was equally distributed at 3 months (n = 6) and 14 months (n = 5), In conclusion, thyroid dysfunction is not a rare complication even without pretransplant TBI conditioning regimen. Hypothyroidism prevalence was 10%, and ETS, which was more frequently observed, displayed a dismal predictive value at 3 months.
引用
收藏
页码:453 / 457
页数:5
相关论文
共 25 条
[1]  
BLAISE D, 1992, BLOOD, V79, P2578
[2]  
BORGSTROM B, 1994, BONE MARROW TRANSPL, V13, P59
[3]  
BOULAD F, 1995, BONE MARROW TRANSPL, V15, P71
[4]  
BRENT GA, 1986, J CLIN ENDOCR METAB, V63, P1
[5]  
CARLSON K, 1992, BONE MARROW TRANSPL, V10, P123
[6]   MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - A RANDOMIZED STUDY COMPARING CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION WITH BUSULFAN AND CYCLOPHOSPHAMIDE [J].
CLIFT, RA ;
BUCKNER, CD ;
THOMAS, ED ;
BENSINGER, WI ;
BOWDEN, R ;
BRYANT, E ;
DEEG, HJ ;
DONEY, KC ;
FISHER, LD ;
HANSEN, JA ;
MARTIN, P ;
MCDONALD, GB ;
SANDERS, JE ;
SCHOCH, G ;
SINGER, J ;
STORB, R ;
SULLIVAN, KM ;
WITHERSPOON, RP ;
APPELBAUM, FR .
BLOOD, 1994, 84 (06) :2036-2043
[7]  
DESIMONE M, 1995, BONE MARROW TRANSPL, V15, P227
[8]   ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA IN FIRST CHRONIC PHASE - A RANDOMIZED TRIAL OF BUSULFAN-CYTOXAN VERSUS CYTOXAN-TOTAL-BODY IRRADIATION AS PREPARATIVE REGIMEN - A REPORT FROM THE FRENCH-SOCIETY-OF-BONE-MARROW-GRAFT (SFGM) [J].
DEVERGIE, A ;
BLAISE, D ;
ATTAL, M ;
TIGAUD, JD ;
JOUET, JP ;
VERNANT, JP ;
BORDIGONI, P ;
IFRAH, N ;
DAURIAC, C ;
CAHN, JY ;
LIOURE, B ;
TROUSSARD, X ;
REIFFERS, J ;
GRATECOS, N ;
MILPIED, N ;
BELANGER, C ;
GUYOTAT, D ;
TILLY, H ;
MICHALLET, M ;
GLUCKMAN, E .
BLOOD, 1995, 85 (08) :2263-2268
[9]  
Galimberti M, 1991, Bone Marrow Transplant, V7 Suppl 2, P74
[10]  
HERSHMAN JM, 1990, BONE MARROW TRANSPL, V6, P49